Want to see IN:SRPL full AI Analyst Report?
Top Page
Shree Ram Proteins Ltd.
(SRPL)
Select Model
Select Model
Rating:44Neutral
Price Target:
₹0.33
▼(-50.00% Downside)
Action:Upgraded
Date:09/24/26
The score is held down primarily by very weak financial performance, including multi-year losses, a collapse in revenue, rising leverage, and eroding equity. Technicals are only mildly supportive with a weak longer-term trend and mixed momentum signals. Valuation is constrained by loss-making results (negative P/E) and no available dividend yield.
Positive Factors
Historical Profitability
The company demonstrated an ability to generate profit in three consecutive years before the recent downturn. This history shows that the operating model has previously supported positive earnings, providing a foundation for recovery if revenue and margins stabilize.
Negative Factors
Severe Earnings Deterioration
The shift from recurring profits to three consecutive years of large losses indicates a substantial deterioration in the economics of the business. Persistent losses can weaken reinvestment capacity, reduce financial resilience, and make a durable earnings recovery dependent on restoring operations and margins.
Read all positive and negative factors
Positive Factors
Negative Factors
Historical Profitability
The company demonstrated an ability to generate profit in three consecutive years before the recent downturn. This history shows that the operating model has previously supported positive earnings, providing a foundation for recovery if revenue and margins stabilize.
Read all positive factors
Shree Ram Proteins Ltd. (SRPL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹145.66M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)0.34
Revenue GrowthN/A
EPS Growth43.06%
CountryIN
Employees24
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Farm Products
Share Statistics
EPS (TTM)-0.68
Shares Outstanding428,400,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.63
Price to Sales (P/S)0.00
P/FCF Ratio9.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Shree Ram Proteins Ltd. Business Overview & Revenue Model
Company Description
Shree Ram Proteins Limited, an Indian company, specializes in the processing of cotton seeds. Its product portfolio is extensive, featuring various cotton seed derivatives like linter, meal, hull, and both wash and refined oils. Beyond cotton, the...
How the Company Makes Money
SRPL generates revenue primarily through the sale of agricultural commodity products and related processed outputs (i.e., revenue recognized when commodities/finished goods are delivered/sold to customers). Key revenue streams typically include (a...
Shree Ram Proteins Ltd. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
33
Negative
Cash Flow
26
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 146.00K | 0.00 | 0.00 | 147.66M | 1.63B | 2.88B |
| Gross Profit | -60.85M | -61.39M | -195.24M | -45.57M | 145.69M | 174.93M |
| EBITDA | -79.56M | -91.70M | -169.38M | -78.65M | 105.07M | 136.20M |
| Net Income | -146.53M | -101.08M | -210.75M | -95.85M | 38.45M | 61.41M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 694.70M | 787.27M | 982.56M | 1.06B | 1.16B |
| Cash, Cash Equivalents and Short-Term Investments | 135.00K | 135.00K | 136.00K | 970.00K | 425.00K | 313.31M |
| Total Debt | 0.00 | 371.45M | 381.37M | 369.40M | 369.48M | 425.14M |
| Total Liabilities | -153.42M | 541.28M | 532.49M | 517.65M | 500.07M | 638.17M |
| Stockholders Equity | 153.42M | 153.42M | 254.79M | 464.91M | 560.73M | 522.31M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.73M | -12.81M | 5.83M | -214.48M | 360.12M |
| Operating Cash Flow | 0.00 | 9.73M | -12.81M | 5.86M | -202.00M | 362.66M |
| Investing Cash Flow | 0.00 | 283.00K | 0.00 | 9.04M | -12.39M | -2.44M |
| Financing Cash Flow | 0.00 | -10.02M | 11.97M | -14.35M | -98.50M | -56.87M |
Shree Ram Proteins Ltd. Technical Analysis
Negative
0.66
Price Trends
0.34
Positive
0.36
Negative
0.46
Negative
Market Momentum
>-0.01
Negative
42.95
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SRPL, the sentiment is Negative. The current price of 0.66 is above the 20-day moving average (MA) of 0.34, above the 50-day MA of 0.34, and above the 200-day MA of 0.46, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.95 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SRPL.
Shree Ram Proteins Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹5.27B | 11.09 | ― | 0.06% | 41.38% | 100.73% | |
66 Neutral | ₹23.27B | 13.26 | ― | 0.61% | 18.28% | 202.79% | |
63 Neutral | ₹126.63B | 27.67 | ― | 1.96% | 8.58% | -1.86% | |
61 Neutral | ₹8.09B | 9.64 | ― | 1.22% | 10.24% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
44 Neutral | ₹145.66M | -0.50 | ― | ― | ― | 43.06% | |
42 Neutral | ₹360.69M | -3.51 | ― | 1.06% | 296.49% | 19.23% |
* General Sector Average
IN:SRPL
Shree Ram Proteins Ltd.
0.34
-0.46
-57.50%
IN:DBOL
Dhampur Bio Organics Ltd
122.05
41.87
52.21%
IN:GODREJAGRO
Godrej Agrovet Limited
643.10
-34.58
-5.10%
IN:MGEL
Mangalam Global Enterprise Ltd.
15.91
0.00
0.00%
IN:SANWARIA
Sanwaria Consumer Ltd
0.49
0.00
0.00%
IN:VENKEYS
Venky's (India) Limited
1,631.05
150.58
10.17%
Shree Ram Proteins Ltd. Corporate Events
Shree Ram Proteins Shareholders Approve Related-Party Sale of Undertaking via E-Voting
Aug 18, 2026
Shree Ram Proteins Ltd. conducted an Extraordinary General Meeting (EOGM) on March 5, 2026, via video conferencing, where shareholders participated through remote and live e-voting facilitated by NSDL in compliance with Ministry of Corporate Affai...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.